(Q48297395)

10 February 2018

title

Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults (English)

1 reference

10 February 2018

1 reference

obstructive sleep apnea

1 reference

Qi-Chang Lin

1

1 reference

10 February 2018

Xiao-Bin Zhang

2

1 reference

10 February 2018

Gong-Ping Chen

3

1 reference

10 February 2018

Dou-Yu Huang

4

1 reference

10 February 2018

Hai-Bo Din

5

1 reference

10 February 2018

Ai-Zhong Tang

6

1 reference

10 February 2018

publication date

17 June 2011

1 reference

10 February 2018

published in

Sleep and Breathing

1 reference

10 February 2018

volume

16

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

571-578

1 reference

10 February 2018

The occurrence of sleep-disordered breathing among middle-aged adults

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Cardiovascular and metabolic effects of CPAP in obese males with OSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Obstructive sleep apnoea is associated with risk factors comprising the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Association of sleep apnea and type II diabetes: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Intermittent hypoxia increases insulin resistance in genetically obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11325-011-0544-7

Relationship of metabolic syndrome and obstructive sleep apnea.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21681412

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phasic or transient? Comment on the terminology of the AASM manual for the scoring of sleep and associated events.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21681412

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The metabolic syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21681412

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11325-011-0544-7

1 reference

10 February 2018

1 reference

10 February 2018